Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.220
+0.040 (3.39%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $165.98 million as of August 7, 2026. Its market cap has increased by 10.84% in one year.
Market Cap
165.98M
Enterprise Value
119.09M
1-Year Change
10.84%
Ranking
Category
Stock Price
$1.22
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $165.98M, a decrease of -54.33%. That is a compound annual growth rate of -10.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 165.98M | -19.11% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 175.98M |
| Armata Pharmaceuticals | 172.91M |
| Nkarta | 172.42M |
| Aardvark Therapeutics | 172.35M |
| LENZ Therapeutics | 168.06M |
| OnKure Therapeutics | 167.65M |
| Innate Pharma | 163.74M |
| Caribou Biosciences | 163.65M |